Telomerase activity and its inhibition in benign and malignant breast lesions

Journal of Pathology

Volumn 183, Issue 1, 1997, Pages 57-61

  Sugino, Takashi ^a   Yoshida, Kazuhiro ^a   Bolodeoku, John ^a   Tarin, David ^a   Goodison, Steve ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Breast cancer; Telomerase assay; Telomerase inhibitors; Telomerase regulation

Indexed keywords

TELOMERASE;

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST FIBROADENOMA; CARCINOMA IN SITU; CELL IMMORTALIZATION; CELL LYSATE; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERE;

BREAST NEOPLASMS; CARCINOMA IN SITU; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030812868     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199709)183:1<57::AID-PATH1114>3.0.CO;2-4     Document Type: Article

References (17)

1. Shay JW, Pereira-Smith OM, Wright WE. A role for both Rb and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196: 33-39.
2. Rhyu MS. Telomeres, telomerase and immortality. J Natl Cancer Inst 1995: 87: 884-894.
3. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
4. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatysek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcome. Nature Med 1995; 1: 249-255.
5. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902.
6. Tahara H, Kuniyasu H, Yasui W, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245-1251.
7. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-2736.
8. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bachetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-2536.
9. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-2320.
10. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-9086.
11. Wright WE, Shay JW, Piatyszek A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794-3795.
12. Sugino T, Yoshida K, Bolodeoku J, et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens including fine needle aspirates. Int J Cancer (Pred Oncol) 1996; 69: 301-306.
13. Parkinson EK. Do telomerase antagonists represent a novel anti-cancer strategy? Br J Cancer 1996; 73: 1-4.
14. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88: 1161-122.
15. Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-369.
16. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14: 4240-4248.
17. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79-82.